Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Dudley

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|October 1, 1990
Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infectionsC R Marchbanks, D J Mikolich, K H Mayer, et al.
The American Journal of Medicine|April 27, 1987
Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic modelM N Dudley, H D Mandler, D Gilbert, et al.
The Journal of Infectious Diseases|September 1, 1992
Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complexM N Dudley, K K Graham, S Kaul, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trialK A Jackson, S E Rosenbaum, B M Kerr, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infectionA H Strayer, D H Gilbert, P Pivarnik, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complexC M Horton, M N Dudley, S Kaul, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitroJ A Bilello, P A Bilello, J J Kort, et al.
The Journal of Infectious Diseases|March 1, 1989
The role of the pharmacist in antimicrobial agent therapyS L Barriere, M N Dudley, S F Kowalsky, et al.
Reviews of Infectious Diseases|November 1, 1984
Tissue penetration and half-life of cefonicidC H Nightingale, R Quintiliani, M N Dudley, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected womenS M Geletko, M Segarra, K H Mayer, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|October 1, 1990
Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infectionsC R Marchbanks, D J Mikolich, K H Mayer, et al.
The American Journal of Medicine|April 27, 1987
Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic modelM N Dudley, H D Mandler, D Gilbert, et al.
The Journal of Infectious Diseases|September 1, 1992
Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complexM N Dudley, K K Graham, S Kaul, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trialK A Jackson, S E Rosenbaum, B M Kerr, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infectionA H Strayer, D H Gilbert, P Pivarnik, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complexC M Horton, M N Dudley, S Kaul, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitroJ A Bilello, P A Bilello, J J Kort, et al.
The Journal of Infectious Diseases|March 1, 1989
The role of the pharmacist in antimicrobial agent therapyS L Barriere, M N Dudley, S F Kowalsky, et al.
Reviews of Infectious Diseases|November 1, 1984
Tissue penetration and half-life of cefonicidC H Nightingale, R Quintiliani, M N Dudley, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected womenS M Geletko, M Segarra, K H Mayer, et al.
Pageof 7